SEC Tracker
Get the app

Replimune Group REPL

Replimune Group reports Q2 2026 results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Q2 2026 financial results announced
  2. Exhibit 99.1 includes the news release

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Replimune Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025